Colon Cancer Alliance raises awareness in Denver with ‘Undy’ run
DENVER — The Colon Cancer Alliance’s Denver Undy 5000 5K run held at City Park last month had more than 1,300 people wearing underwear, boxer shorts or silly costumes helping to bring greater awareness to colon cancer, the second-leading cause of cancer death in the United States.
“Denver has done it again,” stated Andrew Spiegel, CEO of the Colon Cancer Alliance. “The Undy 5000 was a great success. We had 74 survivors in attendance who were recognized for their valiant effort in beating this disease. And, to top it off, Denver supporters helped us raise more than $130,000.” That marks the third consecutive year that the Undy 5000 5K run eclipsed the $100,000 mark in raised funds.
Event proceeds are used to support and build the Colon Cancer Alliance’s national and local patient support and public awareness programs. In addition, a portion of the proceeds from the Denver Undy 5000 will go to the Colorado Colorectal Screening Program at the University of Colorado Cancer Center to fund services for individuals diagnosed with colon cancer.
The maker of Dulcolax is the presenting sponsor of the 2011 Undy 5000 races. As the No.-1 doctor-recommended stimulant for constipation relief, Dulcolax reminded everyone over the age of 50 years or those with a family history of colon cancer that a colonoscopy can save lives.
Additional national sponsors included the American Society of Colon and Rectal Surgeons, Amgen, Genentech and Salix Pharmaceuticals. Local sponsors included Arapahoe Gastroenterology, RMGA, South Denver Gastroenterology, Diversified Radiology of Colorado, The Cancer Center Lutheran Medical Center, University of Colorado Cancer Center, Comprehensive Cancer Center, Saint Joseph Hospital, Ah-Some Photography and Tony’s Market.
More information about the Undy 5000 is available online at Undy5000.org.
Court affirms decision that Watson Pharmaceuticals’ generic versions of Mucinex products do not infringe on any patents
PARSIPPANY, N.J. — Watson Pharmaceuticals last week confirmed that the United States Court of Appeals for the Federal Circuit has affirmed the United States District Court for the Southern District of Florida’s February 2011 decision that Watson’s generic versions of Mucinex, Mucinex D and Mucinex DM extended-release products do not infringe Reckitt Benckiser’s U.S. Patent No. 6,372,252.
Watson stated it is continuing to seek final approval of the products from the Food and Drug Administration.
In 2009, Reckitt Benckiser sued Watson for patent infringement related to Watson’s filing of three abbreviated new drug applications for generic versions of Reckitt’s Mucinex line of products. The Mucinex products had total U.S. sales of approximately $500 million for the 12 months ended Dec. 31, 2010, Watson noted, citing SymphonyIRI Group data.
Study finds vitamin D deficiency could increase chance of muscle injury in athletes
SAN DIEGO — Vitamin D deficiency may increase the chance of muscle injuries in elite athletes, specifically NFL football players, suggested a recent study presented last week at the American Orthopaedic Society for Sports Medicine’s annual meeting.
“Eighty percent of the football team we studied had vitamin D insufficiency. African-American players and players who suffered muscle injuries had significantly lower levels,” stated Michael Shindle, lead researcher and member of Summit Medical Group.
Researchers identified 89 football players from a single NFL team and provided laboratory testing of vitamin D levels in spring 2010 as part of routine preseason evaluations. The mean age of the players was 25. The team provided data to determine the number of players who had lost time due to muscle injuries. Vitamin D levels then were classified based on player race and time lost due to muscle injury.
Twenty-seven players had deficient levels, and an additional 45 had levels consistent with insufficiency. Seventeen players had values within normal limits. The mean vitamin D level in white players was 30.3 ng/mL, while the mean level for black players was 20.4 ng/mL. Sixteen players suffered a muscle injury with a mean vitamin D level of 19.9.
“Screening and treatment of vitamin D insufficiency in professional athletes may be a simple way to help prevent injuries,” stated Scott Rodeo, co-chief of the Sports Medicine and Shoulder Service at the Hospital for Special Surgery.
“Further research also needs to be conducted in order to determine if increasing vitamin D leads to improved maximum muscle function,” added Joseph Lane, director of the Metabolic Bone Disease Service at the Hospital for Special Surgery.